GlassScriptPhysician profile
Monica Wonnacott
NPI 1003029935
$653.11
in general payments reported to CMS, 2019-2025
20 companies · $85.61 in 2025
The $85.61 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $56.06 · 2021: $62.49 · 2022: $81.39 · 2023: $190 · 2024: $50.27 · 2025: $85.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $89.83 | 2019-2023 | |
| Sanofi Pasteur INC. | $81.40 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.61 | 2020-2021 | |
| Abbott Laboratories | $54.41 | 2023-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $52.51 | 2019-2023 | Bexsero, Shingrix, Arexvy |
| Abbvie INC. | $34.81 | 2022 | |
| Cranial Technologies, INC | $33.97 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $30.90 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $30.46 | 2024-2025 | Zoryve |
| Corium, LLC | $23.84 | 2022 | |
| Novo Nordisk INC | $23.42 | 2019-2020 | |
| Pfizer INC. | $22.74 | 2022 | |
| Merck Sharp & Dohme LLC | $18.74 | 2024 | Vaxelis, Gardasil 9, Gardasil |
| Tris Pharma INC | $14.12 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.10 | 2025 | Jornay Pm |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.71 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.65 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.81 | 2023 | Qelbree |
| Verrica Pharmaceuticals INC. | $12.72 | 2023 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Wonnacott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.